Advenchen Laboratories, Llc
Clinical trials sponsored by Advenchen Laboratories, Llc, explained in plain language.
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a combination of two drugs, AL8326 and toripalimab, in people with advanced solid tumors that have not responded to standard treatments or have no other options. The goal is to find the best dose and see if the combination can shrink tumors. About 228 adults will…
Phase: PHASE1, PHASE2 • Sponsor: Advenchen Laboratories, LLC • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New hope for rare sarcoma: phase 3 drug trial now recruiting
Disease control Recruiting nowThis study tests a drug called AL3818 (anlotinib) for people with a rare cancer called alveolar soft part sarcoma that has spread or cannot be removed by surgery. The goal is to see if the drug can shrink tumors or slow the cancer's growth. Participants take the drug by mouth dai…
Phase: PHASE3 • Sponsor: Advenchen Laboratories, LLC • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC